Similar Papers

Paper Title
Journal
Date
Author
MEK Inhibition in CAR-T Cells Prevents Exhaustion and Terminal Differentiation Via Downregulating C-Fos and JunB
...
Blood | VOL. 140
, et. al. ...
15 Nov 2022
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.
Christopher A Klebanoff ... Robert L Eil
JCI Insight | VOL. 2
Christopher A Klebanoff, et. al.Christopher A Klebanoff ... Robert L Eil
07 Dec 2017
Identification of IL-4 As a Key Regulator of CAR T-Cell Exhaustion Using Functional Genomics and Correlates of the Zuma-1 Clinical Trial
Carli M Stewart ... Saad S Kenderian
Blood | VOL. 140
Carli M Stewart, et. al.Carli M Stewart ... Saad S Kenderian
15 Nov 2022
1143 CART cell function improves with IL-4 pathway editing
Carli M Stewart ... Saad S Kenderian
Journal for ImmunoTherapy of Cancer | VOL. 12
Carli M Stewart, et. al.Carli M Stewart ... Saad S Kenderian
01 Nov 2024
View more papers

More From: Cancer discovery

Paper Title
Journal
Date
Author
Prenatal exposure to chemotherapy increases the mutation burden in human neonatal hematopoietic stem cells.
Ilana Struys ... Frédéric Amant
Cancer discovery | VOL. -
Ilana Struys, et. al.Ilana Struys ... Frédéric Amant
24 Jan 2025
Bone-Induced Her2 Promotes Secondary Metastasis in HR+/Her2- Breast Cancer.
Rahat Alam ... Igor L Bado
Cancer discovery | VOL. -
Rahat Alam, et. al.Rahat Alam ... Igor L Bado
21 Jan 2025
The FBXO45-GEF-H1 axis controls germinal center formation and B-cell lymphomagenesis.
Anagh A Sahasrabuddhe ... Kojo S.J Elenitoba-Johnson
Cancer discovery | VOL. -
Anagh A Sahasrabuddhe, et. al.Anagh A Sahasrabuddhe ... Kojo S.J Elenitoba-Johnson
17 Jan 2025
PIN1 prolyl isomerase promotes initiation and progression of bladder cancer through the SREBP2-mediated cholesterol biosynthesis pathway.
Xue Wang ... Tony Hunter
Cancer discovery | VOL. -
Xue Wang, et. al.Xue Wang ... Tony Hunter
14 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.